Predictive Oncology ROE 2010-2024 | POAI
Current and historical return on equity (ROE) values for Predictive Oncology (POAI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Predictive Oncology ROE - Return on Equity Historical Data |
Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
2024-09-30 |
$-0.01B |
$0.00B |
-288.89% |
2024-06-30 |
$-0.01B |
$0.00B |
-185.71% |
2024-03-31 |
$-0.01B |
$0.00B |
-143.59% |
2023-12-31 |
$-0.01B |
$0.01B |
-96.30% |
2023-09-30 |
$-0.02B |
$0.01B |
-105.88% |
2023-06-30 |
$-0.02B |
$0.02B |
-88.37% |
2023-03-31 |
$-0.03B |
$0.02B |
-95.24% |
2022-12-31 |
$-0.03B |
$0.02B |
-81.30% |
2022-09-30 |
$-0.03B |
$0.03B |
-70.92% |
2022-06-30 |
$-0.03B |
$0.03B |
-65.41% |
2022-03-31 |
$-0.02B |
$0.04B |
-42.70% |
2021-12-31 |
$-0.02B |
$0.04B |
-45.20% |
2021-09-30 |
$-0.02B |
$0.05B |
-65.71% |
2021-06-30 |
$-0.03B |
$0.05B |
-96.15% |
2021-03-31 |
$-0.03B |
$0.04B |
-165.08% |
2020-12-31 |
$-0.03B |
$0.00B |
-291.89% |
2020-09-30 |
$-0.03B |
$0.01B |
-266.67% |
2020-06-30 |
$-0.03B |
$0.01B |
-200.00% |
2020-03-31 |
$-0.02B |
$0.01B |
-137.50% |
2019-12-31 |
$-0.02B |
$0.01B |
-148.15% |
2019-09-30 |
$-0.01B |
$0.02B |
-83.72% |
2019-06-30 |
$-0.01B |
$0.02B |
-128.00% |
2019-03-31 |
$-0.01B |
$0.00B |
-733.33% |
2018-12-31 |
$-0.01B |
$0.00B |
-363.64% |
2018-09-30 |
$-0.01B |
$0.00B |
-228.57% |
2018-06-30 |
$-0.01B |
$0.00B |
-184.62% |
2018-03-31 |
$-0.01B |
$0.01B |
-215.38% |
2017-12-31 |
$-0.01B |
$0.00B |
-200.00% |
2017-09-30 |
$-0.01B |
$0.00B |
-240.00% |
2017-06-30 |
$-0.01B |
$0.00B |
-300.00% |
2017-03-31 |
$-0.01B |
$0.00B |
-400.00% |
2016-12-31 |
$-0.01B |
$0.00B |
-560.00% |
2016-09-30 |
$-0.01B |
$0.00B |
-400.00% |
2016-06-30 |
$-0.01B |
$0.00B |
-228.57% |
2016-03-31 |
$-0.01B |
$0.00B |
-342.86% |
2015-12-31 |
$-0.00B |
$0.00B |
800.00% |
2015-09-30 |
$-0.00B |
$0.01B |
133.33% |
2015-06-30 |
$-0.00B |
$-0.01B |
72.73% |
2015-03-31 |
$-0.01B |
$-0.01B |
105.26% |
2014-12-31 |
$-0.01B |
$-0.01B |
186.67% |
2014-09-30 |
$-0.01B |
$-0.00B |
233.33% |
2014-06-30 |
$-0.01B |
$-0.00B |
444.44% |
2014-03-31 |
$-0.01B |
$-0.00B |
400.00% |
2013-12-31 |
$-0.01B |
$-0.00B |
360.00% |
2013-09-30 |
$-0.01B |
$-0.00B |
360.00% |
2013-06-30 |
$-0.01B |
$-0.00B |
290.91% |
2013-03-31 |
$-0.01B |
$-0.00B |
360.00% |
2012-12-31 |
$-0.01B |
$-0.00B |
320.00% |
2012-09-30 |
$-0.01B |
$-0.00B |
360.00% |
2012-06-30 |
$-0.01B |
$-0.00B |
280.00% |
2012-03-31 |
$-0.01B |
$-0.00B |
200.00% |
2011-12-31 |
$-0.00B |
$-0.00B |
177.78% |
2011-09-30 |
$-0.00B |
$-0.00B |
50.00% |
2011-06-30 |
$0.00B |
$-0.00B |
0.00% |
2011-03-31 |
$0.00B |
$-0.00B |
0.00% |
2010-12-31 |
$-0.00B |
$-0.00B |
50.00% |
2010-09-30 |
$-0.00B |
$-0.00B |
50.00% |
2010-06-30 |
$-0.00B |
$-0.00B |
100.00% |
2010-03-31 |
$-0.00B |
$-0.00B |
200.00% |
2009-12-31 |
$-0.00B |
$-0.00B |
300.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.005B |
$0.002B |
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|